Apolipoprotein C-III, familial chylomicronemia syndrome, and olezarsen

Reducing the synthesis of apoC-III reduces fasting triglycerides in individuals lacking lipoprotein lipase activity. Recently, Stroes et al. published a phase 3 trial on the effects of olezarsen, a third-generation antisense oligonucleotide that blocks apoC-III mRNA, on triglycerides and risk of acu...

Full description

Saved in:
Bibliographic Details
Published in:Med (New York, N.Y. : Online) Vol. 5; no. 6; p. 493
Main Authors: Valdivielso, Pedro, Coca Prieto, Inmaculada
Format: Journal Article
Language:English
Published: United States 14-06-2024
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Reducing the synthesis of apoC-III reduces fasting triglycerides in individuals lacking lipoprotein lipase activity. Recently, Stroes et al. published a phase 3 trial on the effects of olezarsen, a third-generation antisense oligonucleotide that blocks apoC-III mRNA, on triglycerides and risk of acute pancreatitis.
AbstractList Reducing the synthesis of apoC-III reduces fasting triglycerides in individuals lacking lipoprotein lipase activity. Recently, Stroes et al. published a phase 3 trial on the effects of olezarsen, a third-generation antisense oligonucleotide that blocks apoC-III mRNA, on triglycerides and risk of acute pancreatitis.
Author Valdivielso, Pedro
Coca Prieto, Inmaculada
Author_xml – sequence: 1
  givenname: Pedro
  surname: Valdivielso
  fullname: Valdivielso, Pedro
  email: valdivielso@uma.es
  organization: Lipid Unit, Servicio de Medicina Interna, Hospital Universitario Virgen de la Victoria, Departamento de Medicina y Dermatología, Instituto de Investigación Biomédica (IBIMA-Plataforma BIONAND), Universidad de Málaga, Málaga, Spain. Electronic address: valdivielso@uma.es
– sequence: 2
  givenname: Inmaculada
  surname: Coca Prieto
  fullname: Coca Prieto, Inmaculada
  organization: Lipid Unit, Servicio de Medicina Interna, Hospital Universitario Virgen de la Victoria, Departamento de Medicina y Dermatología, Instituto de Investigación Biomédica (IBIMA-Plataforma BIONAND), Universidad de Málaga, Málaga, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38878767$$D View this record in MEDLINE/PubMed
BookMark eNo1j0tOwzAARC0EoqX0AiyQD9AE2_F3WUUUIlViA-vKvwhXsR05ZRFOTyRgMZrdvHl34Drl5AF4wKjGCPOncx29O9cEEVojViNEr8CacM4r3lC0AttpOiOECMMNVuQWrBophRRcrMFhP-YhjHks-eJDgm3Vdd0O9jqGIegB2s95yDHYshBj0HCakys5-h3UycE8-G9dJp_uwU2vh8lv_3oDPg7P7-1rdXx76dr9sbKkEZeKSW0dV7QxkijqeoYlUlYoiVWPl9jlk2e95EZjyYhhVAmDDVW94Yw7Tzbg8Xd3_DKL82ksIeoyn_6FyA_8gk6V
ContentType Journal Article
Copyright Copyright © 2024 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2024 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1016/j.medj.2024.05.004
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 2666-6340
ExternalDocumentID 38878767
Genre Journal Article
GroupedDBID 0R~
53G
AALRI
AAMRU
AAXUO
AKRWK
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
EBS
ECM
EIF
FDB
M41
NPM
ID FETCH-LOGICAL-c237t-58acd6943b8294df51809c79819f119fc767e5f86ba1852b5497b1b49fb656de2
IngestDate Sat Nov 02 12:13:38 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Copyright © 2024 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c237t-58acd6943b8294df51809c79819f119fc767e5f86ba1852b5497b1b49fb656de2
PMID 38878767
ParticipantIDs pubmed_primary_38878767
PublicationCentury 2000
PublicationDate 2024-06-14
PublicationDateYYYYMMDD 2024-06-14
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-06-14
  day: 14
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Med (New York, N.Y. : Online)
PublicationTitleAlternate Med
PublicationYear 2024
SSID ssj0002513192
Score 2.3104198
Snippet Reducing the synthesis of apoC-III reduces fasting triglycerides in individuals lacking lipoprotein lipase activity. Recently, Stroes et al. published a phase...
SourceID pubmed
SourceType Index Database
StartPage 493
SubjectTerms Apolipoprotein C-III - blood
Apolipoprotein C-III - genetics
Benzimidazoles
Humans
Hyperlipoproteinemia Type I - blood
Hyperlipoproteinemia Type I - genetics
Oligonucleotides - pharmacology
Oligonucleotides - therapeutic use
Oligonucleotides, Antisense - pharmacology
Oligonucleotides, Antisense - therapeutic use
Pancreatitis - genetics
Triglycerides - blood
Title Apolipoprotein C-III, familial chylomicronemia syndrome, and olezarsen
URI https://www.ncbi.nlm.nih.gov/pubmed/38878767
Volume 5
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NS8MwFA9OYewifn9LDt5cx5amTXscc2M7TAQneBtJm6DDbgP14l_vS9J0tSrqwcNKSSAteb-9vPf63vshdMHBJJCkIz3BSeJRTuBOU4YxFoRJmyilhA64DW_Z9X101af91RfT1di_ShrGQNa6cvYP0i4WhQG4B5nDFaQO11_JvatpF5YL039BV_R5o9FI76OJZOjwePIAPnqm8_DmMnvkRc8Cl8e5eJJv4O3mJWKO7EmmX_H2mIBCuVtpTt71pKu84NRd2BRgWL_41gFn5-UN-OeGvgnUU8Z1JmweF8jDD4TqNClb9tmSRk3BCR96oW-bLjmdGpSgU9aP1NIhftLbNoQwa4EFMGvpx5h2qpaYuCS0ZWak5oNmBC3Ofp6t9NJ2UzVUA8tIG8-9cRGRA0sP9BHJK6tsEmD1fRqo7tao-CHGHplsoc3ckcBdi4BttCbnO6g-zlMldtHgIxCwAUITOxjgCgywg0ETAwhwAYI9dDfoT3pDLyfN8BLisxcviHiShjH1RURimqpAN2hLWAyWn-rAL4FXl4GKQsF13bwIaMxER9BYCTDtU0n20focnnyIsIJ5KlI_5YJSJVSkuxuythC-Tzgj7SN0YHdgurSdUaZub46_nTlBjRWKTtGGgr-dPEO15_T13IjjHYP6Sf4
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Apolipoprotein+C-III%2C+familial+chylomicronemia+syndrome%2C+and+olezarsen&rft.jtitle=Med+%28New+York%2C+N.Y.+%3A+Online%29&rft.au=Valdivielso%2C+Pedro&rft.au=Coca+Prieto%2C+Inmaculada&rft.date=2024-06-14&rft.eissn=2666-6340&rft.volume=5&rft.issue=6&rft.spage=493&rft_id=info:doi/10.1016%2Fj.medj.2024.05.004&rft_id=info%3Apmid%2F38878767&rft_id=info%3Apmid%2F38878767&rft.externalDocID=38878767